Accendra Health Sees 2026 EBITDA Up to 30% Below Prior Outlook
Accendra Health expects 2026 net revenue at the bottom end of its prior $2.45B–$2.55B range and adjusted EBITDA up to 30% below the prior $310M midpoint. No prior-period comparison was provided.
Accendra Health expects 2026 net revenue at the bottom end of its prior $2.45B—$2.55B range and adjusted EBITDA could be up to 30% below the prior $310M midpoint. No prior-period comparison was provided.Material DetailsContext by AI AnalystThis is an early-stage turnaround update, with management s…